anayamalik, Author at European Medical Journal - Page 11 of 96

Demand for Rheumatology Advice Lines Outpaces Resources

A new survey highlights that patients with rheumatoid arthritis want faster and more personal access to rheumatology telephone advice lines, underscoring the growing strain on these services.

Emotional Support Fuels Growth in Skin Disorders

Patients with psychophysiological skin disorders such as atopic dermatitis, psoriasis, pruritus, and alopecia experience measurable benefits in post-traumatic growth when they receive emotional and informational support, according to new research.

Multiple Barriers Delay Radiation for Head and Neck Cancer

Timely initiation of postoperative radiation therapy (PORT) within 6 weeks of surgery is a critical factor in improving outcomes for patients with head and neck squamous cell carcinoma.

Global Analysis Reveals Rising Burden of Complex PTSD

Complex post-traumatic stress disorder (C-PTSD) affects nearly one in ten people worldwide, according to a new systematic review and meta-analysis examining community prevalence of this ICD-11 defined condition.

WCLC 2025: IFITM3 May Improve Immunotherapy Outcomes in SCLC

Interferon-induced transmembrane protein 3 (IFITM3) has been identified as a critical regulator of immunotherapy response in small cell lung cancer (SCLC), with new findings showing its potential role as both a predictive biomarker and therapeutic target.

Mpox Shifts to Global Threat with Evolving Spread

Mpox has rapidly transitioned from a neglected zoonosis to a global health concern, with recent outbreaks reshaping its epidemiology, clinical features, and management strategies.

Bone Density After Hip Surgery Mostly Unchanged

Bone mineral density (BMD) assessment using radiofrequency echographic multispectrometry (REMS) shows that age, sex, and BMI remain the strongest determinants of bone health, even in the context of total hip replacement surgery.

Scalp Metastases from Breast Cancer Show Distinct Dermoscopic Patterns

Scalp cutaneous metastases from breast carcinoma may present with varied clinical patterns, and new research highlights distinct dermoscopic features that could aid earlier recognition.

Managing Ocular Side Effects of ADCs in Gynecologic Cancer

Ocular toxicities are an emerging challenge in the management of gynecologic cancers treated with antibody drug conjugates, with new research outlining prevention and care strategies to safeguard patient outcomes.

Schizophrenia Diagnosis Reframed in ICD-11 Criteria

The transition from ICD-10 to ICD-11 has introduced substantial revisions in the classification of schizophrenia and catatonia, reshaping diagnostic approaches for clinicians worldwide.